Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,438 | 388 | 60.3% |
| Travel and Lodging | $6,027 | 16 | 38.5% |
| Education | $176.43 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,121 | 17 | $0 (2019) |
| GlaxoSmithKline, LLC. | $2,812 | 87 | $0 (2024) |
| Covidien LP | $2,783 | 7 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $776.95 | 7 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $719.91 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $662.07 | 29 | $0 (2024) |
| Olympus Corporation of the Americas | $590.41 | 6 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $462.92 | 10 | $0 (2023) |
| PFIZER INC. | $386.37 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $385.63 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $691.62 | 34 | Takeda Pharmaceuticals U.S.A., Inc. ($314.77) |
| 2023 | $1,347 | 58 | GlaxoSmithKline, LLC. ($331.18) |
| 2022 | $677.15 | 30 | GlaxoSmithKline, LLC. ($369.35) |
| 2021 | $374.83 | 24 | PFIZER INC. ($72.69) |
| 2020 | $740.53 | 36 | Olympus Corporation of the Americas ($201.97) |
| 2019 | $4,851 | 60 | Covidien LP ($2,783) |
| 2018 | $4,568 | 94 | Edwards Lifesciences Corporation ($2,502) |
| 2017 | $2,392 | 72 | Teva Pharmaceuticals USA, Inc. ($762.11) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $18.10 | General |
| 12/10/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Pulmonology | ||||||
| 11/13/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $0.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $33.31 | General |
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $18.54 | General |
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $105.21 | General |
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Immunology | ||||||
| 07/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/21/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 06/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $26.44 | General |
| 04/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 725 | 1,065 | $203,745 | $92,070 |
| 2022 | 13 | 524 | 816 | $156,570 | $73,921 |
| 2021 | 15 | 701 | 1,122 | $224,242 | $111,488 |
| 2020 | 14 | 773 | 1,307 | $264,708 | $128,576 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 146 | 302 | $61,608 | $27,037 | 43.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 64 | 147 | $49,980 | $24,027 | 48.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 97 | 97 | $26,190 | $12,673 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 131 | $20,960 | $11,546 | 55.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 115 | $14,950 | $7,005 | 46.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $4,500 | $2,908 | 64.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 38 | $4,940 | $1,998 | 40.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $3,800 | $1,743 | 45.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 26 | 26 | $2,470 | $873.99 | 35.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 21 | 21 | $1,995 | $600.20 | 30.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 15 | $1,560 | $371.10 | 23.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 15 | 15 | $1,365 | $355.98 | 26.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 31 | $372.00 | $260.40 | 70.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $2,275 | $225.04 | 9.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 14 | 14 | $1,330 | $128.38 | 9.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 15 | 15 | $1,425 | $101.70 | 7.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $1,925 | $86.24 | 4.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 12 | 12 | $1,860 | $74.88 | 4.0% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 24 | 24 | $240.00 | $55.68 | 23.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 60 | 148 | $50,320 | $25,785 | 51.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 108 | 195 | $39,780 | $15,505 | 39.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 157 | $20,410 | $8,509 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 90 | $14,400 | $8,419 | 58.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 52 | $14,040 | $7,930 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 59 | $7,670 | $3,419 | 44.6% |
About Dr. Michael Snyder, MD
Dr. Michael Snyder, MD is a Critical Care Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457389132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Snyder, MD has received a total of $15,642 in payments from pharmaceutical and medical device companies, with $691.62 received in 2024. These payments were reported across 408 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,438).
As a Medicare-enrolled provider, Snyder has provided services to 2,723 Medicare beneficiaries, totaling 4,310 services with total Medicare billing of $406,055. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Indianapolis, IN
- Active Since 06/29/2006
- Last Updated 05/09/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1457389132
Products in Payments
- Puritan Bennett (Device) $2,071
- NUCALA (Biological) $1,476
- TRELEGY ELLIPTA (Drug) $961.61
- PROAIR (Drug) $749.92
- Nellcor (Device) $712.13
- EV1000 Clinical Platform (Device) $709.68
- Olympus Bronchoscopes (Device) $590.41
- GLASSIA (Biological) $437.28
- DUPIXENT (Biological) $405.11
- OFEV (Drug) $388.82
- ELIQUIS (Drug) $303.10
- UPTRAVI (Drug) $259.08
- Prolastin-C Liquid (Biological) $171.36
- FASENRA (Drug) $166.91
- OPSUMIT (Drug) $144.69
- Impella (Device) $144.36
- XOLAIR (Biological) $127.15
- HemoSphere advanced monitoring platform (Device) $126.46
- ANORO ELLIPTA (Drug) $121.40
- INCRUSE (Drug) $116.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Indianapolis
Mithilesh Das, Md, MD
Critical Care Medicine — Payments: $63,055
Shalini Manchanda, Md, MD
Critical Care Medicine — Payments: $43,068
George Rubeiz, M.d, M.D
Critical Care Medicine — Payments: $36,751
Charles Quick, M.d, M.D
Critical Care Medicine — Payments: $9,758
Dr. Alex Baronowsky, Md, MD
Critical Care Medicine — Payments: $4,817
Francis Sheski, Md, MD
Critical Care Medicine — Payments: $4,428